{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:25:12Z","timestamp":1782908712061,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.mcna.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T21:40:15Z","timestamp":1589319615000},"page":"695-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients"],"prefix":"10.1016","volume":"104","author":[{"given":"Michael","family":"Herscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Navalurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeza","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2020.03.003_bib1","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10118","key":"10.1016\/j.mcna.2020.03.003_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(17)32893-3","article-title":"Medications for opioid use disorder: bridging the gap in care","volume":"391","author":"Volkow","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2020.03.003_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002-12","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.mcna.2020.03.003_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2018.06.008","article-title":"US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015","volume":"92","author":"Peterson","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.mcna.2020.03.003_bib5","series-title":"Healthcare cost and utilization project (HCUP) statistical briefs","article-title":"Opioid-related inpatient stays and emergency department visits by state, 2009\u20132014: statistical brief #219","author":"Weiss","year":"2016"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1521-0391.2011.00207.x","article-title":"Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education","volume":"21","author":"Holt","year":"2012","journal-title":"Am J Addict"},{"key":"10.1016\/j.mcna.2020.03.003_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/1471-2458-12-443","article-title":"Estimating the prevalence of illicit opioid use in New York City using multiple data sources","volume":"12","author":"McNeely","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.mcna.2020.03.003_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.004","article-title":"Post-discharge treatment engagement among patients with an opioid-use disorder","volume":"69","author":"Naeger","year":"2016","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2\u20133","key":"10.1016\/j.mcna.2020.03.003_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugalcdep.2006.12.019","article-title":"Overdose after detoxification: a prospective study","volume":"89","author":"Wines","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mcna.2020.03.003_bib11","series-title":"Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5)","year":"2013"},{"issue":"17\u201318","key":"10.1016\/j.mcna.2020.03.003_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1503\/cmaj.160290","article-title":"Caring for patients with opioid use disorder in the hospital","volume":"188","author":"Donroe","year":"2016","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.mcna.2020.03.003_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00001888-200105000-00007","article-title":"Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders","volume":"76","author":"Miller","year":"2001","journal-title":"Acad Med"},{"issue":"9697","key":"10.1016\/j.mcna.2020.03.003_bib14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(09)61036-9","article-title":"Management of injecting drug users admitted to hospital","volume":"374","author":"Haber","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.mcna.2020.03.003_bib16","series-title":"UpToDate","article-title":"Opioid withdrawal in adults: Clinical manifestations, course, assessment, and diagnosis","author":"Sevarino","year":"2019"},{"issue":"18","key":"10.1016\/j.mcna.2020.03.003_bib17","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMra020617","article-title":"Management of drug and alcohol withdrawal","volume":"348","author":"Kosten","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib18","article-title":"Buprenorphine for managing opioid withdrawal","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2020.03.003_bib19","series-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction","author":"Center for Substance Abuse Treatment","year":"2012"},{"issue":"6","key":"10.1016\/j.mcna.2020.03.003_bib20","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir Med J"},{"issue":"7396","key":"10.1016\/j.mcna.2020.03.003_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study","volume":"326","author":"Strang","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2020.03.003_bib22","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"22","key":"10.1016\/j.mcna.2020.03.003_bib23","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2020.03.003_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11606-016-3919-4","article-title":"\u201cIt\u2019s been an experience, a life learning experience\u201d: a qualitative study of hospitalized patients with substance use disorders","volume":"32","author":"Velez","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"issue":"8","key":"10.1016\/j.mcna.2020.03.003_bib25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.mcna.2020.03.003_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11606-010-1311-3","article-title":"A\u00a0transitional opioid program to engage hospitalized drug users","volume":"25","author":"Shanahan","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"issue":"10182","key":"10.1016\/j.mcna.2020.03.003_bib27","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mcna.2020.03.003_bib29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/M18-1652","article-title":"The next stage of buprenorphine care for opioid use disorder","volume":"169","author":"Martin","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2020.03.003_bib30","first-page":"321","article-title":"Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society","volume":"15","author":"Chou","year":"2014","journal-title":"J\u00a0Pain"},{"issue":"5","key":"10.1016\/j.mcna.2020.03.003_bib32","first-page":"358","article-title":"American Society of Addiction Medicine (ASAM) National practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J\u00a0Addict Med"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1073110518782951","article-title":"Improving rural access to opioid treatment programs","volume":"46","author":"Johnson","year":"2018","journal-title":"J\u00a0Law Med Ethics"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib34","article-title":"Managing opioid use disorder during and after acute hospitalization: a case-based review clarifying methadone regulation for acute care settings","volume":"4","author":"Noska","year":"2015","journal-title":"J\u00a0Addict Behav Ther Rehabil"},{"issue":"1","key":"10.1016\/j.mcna.2020.03.003_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.12788\/jhm.2861","article-title":"Expanding treatment opportunities for hospitalized patients with opioid use disorders","volume":"13","author":"Winetsky","year":"2018","journal-title":"J\u00a0Hosp Med"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib36","first-page":"93","article-title":"Buprenorphine pharmacology review: update on transmucosal and long-acting formulations","volume":"13","author":"Coe","year":"2019","journal-title":"J\u00a0Addict Med"},{"issue":"11","key":"10.1016\/j.mcna.2020.03.003_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.JAA.0000525919.14882.ed","article-title":"Why is buprenorphine coformulated with naloxone?","volume":"30","author":"Urnoski","year":"2017","journal-title":"JAAPA"},{"issue":"1","key":"10.1016\/j.mcna.2020.03.003_bib39","first-page":"26","article-title":"Presence or absence of QTc prolongation in buprenorphine-naloxone among youth with opioid dependence","volume":"10","author":"Poole","year":"2016","journal-title":"J\u00a0Addict Med"},{"issue":"22","key":"10.1016\/j.mcna.2020.03.003_bib40","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2020.03.003_bib41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11606-011-1962-8","article-title":"Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care","volume":"27","author":"Schackman","year":"2012","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.mcna.2020.03.003_bib42","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6 Suppl 3","key":"10.1016\/j.mcna.2020.03.003_bib43","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","article-title":"Policy pathways to address provider workforce barriers to buprenorphine treatment","volume":"54","author":"Haffajee","year":"2018","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.mcna.2020.03.003_bib44","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.15288\/jsad.2011.72.1012","article-title":"Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review","volume":"72","author":"Swift","year":"2011","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"10118","key":"10.1016\/j.mcna.2020.03.003_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1155\/2015\/868746","article-title":"Denial of pain medication by health care providers predicts in-hospital illicit drug use among individuals who use illicit drugs","volume":"20","author":"Ti","year":"2015","journal-title":"Pain Res Manag"},{"issue":"12","key":"10.1016\/j.mcna.2020.03.003_bib47","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who\u00a0use illicit drugs: a systematic review","volume":"105","author":"Ti","year":"2015","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.mcna.2020.03.003_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11606-009-0908-x","article-title":"Providers\u2019 experiences treating chronic pain among opioid-dependent drug users","volume":"24","author":"Berg","year":"2009","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2020.03.003_bib49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.addbeh.2009.10.008","article-title":"Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse","volume":"35","author":"Baldacchino","year":"2010","journal-title":"Addict Behav"},{"key":"10.1016\/j.mcna.2020.03.003_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.aan.2019.08.002","article-title":"Perioperative management and analgesia for patients taking buprenorphine and other forms of medication-assisted treatment for substance abuse disorders","volume":"37","author":"Scholzen","year":"2019","journal-title":"Adv Anesth"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib51","first-page":"131","volume":"17","author":"Chou","year":"2016","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.mcna.2020.03.003_bib52","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/TCRM.S141332","article-title":"The challenge of perioperative pain management in opioid-tolerant patients","volume":"13","author":"Coluzzi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10.1016\/j.mcna.2020.03.003_bib53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/15360288.2016.1231734","article-title":"Continuous perioperative sublingual buprenorphine","volume":"30","author":"Silva","year":"2016","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0310057X1304100212","article-title":"Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy","volume":"41","author":"Macintyre","year":"2013","journal-title":"Anaesth Intensive Care"},{"issue":"5","key":"10.1016\/j.mcna.2020.03.003_bib55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MJT.0b013e3181be0804","article-title":"Effectiveness of full agonist opioids in patients stabilized on buprenorphine undergoing major surgery: a case series","volume":"17","author":"Kornfeld","year":"2010","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2020.03.003_bib57","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19com12810","article-title":"Perioperative Buprenorphine Continuous Maintenance and Administration Simultaneous With Full Opioid Agonist","volume":"81","author":"Acampora","year":"2020","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.mcna.2020.03.003_bib58","first-page":"109","article-title":"Primary Care for Persons Who Inject Drugs","volume":"99","author":"Visconti","year":"2019","journal-title":"Am Fam Physician"},{"issue":"22","key":"10.1016\/j.mcna.2020.03.003_bib59","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.2019.6390","article-title":"Preexposure prophylaxis for the prevention of HIV infection: US preventive services task force recommendation statement","volume":"321","author":"US Preventive Services Task Force","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2020.03.003_bib61","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.mcna.2020.03.003_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe programmes in people who inject drugs - An overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.mcna.2020.03.003_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2020.03.003_bib64","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.amepre.2018.12.003","article-title":"U.S. National 90-day readmissions after opioid overdose discharge","volume":"56","author":"Peterson","year":"2019","journal-title":"Am J Prev Med"},{"issue":"1088","key":"10.1016\/j.mcna.2020.03.003_bib65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/postgradmedj-2015-133720","article-title":"Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist","volume":"92","author":"Thakarar","year":"2016","journal-title":"Postgrad Med J"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712520300353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712520300353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T01:08:31Z","timestamp":1593220111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712520300353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0025712520300353"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2020.03.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}